Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC004243 | Panoply™ Human DGAT2 Knockdown Stable Cell Line | Inquiry |
| CSC-SC004243 | Panoply™ Human DGAT2 Over-expressing Stable Cell Line | Inquiry |
| CSC-RT1380 | Human DGAT2 Knockout Cell Line-HeLa | Inquiry |
| CLKO-1232 | DGAT2 KO Cell Lysate-HeLa | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD04805Z | Human DGAT2 adenoviral particles | Inquiry |
| LV10638L | human DGAT2 (NM_032564) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH277357 | shRNA set against Mouse DGAT2 (NM_026384.3) | Inquiry |
| SHH002477 | shRNA set against Mouse Dgat2(NM_026384.3) | Inquiry |
| SHH002495 | shRNA set against Rat Dgat2(NM_001012345.1) | Inquiry |
| SHH277353 | shRNA set against Human DGAT2 (NM_032564.4) | Inquiry |
| SHH277361 | shRNA set against Rat DGAT2 (NM_001012345.1) | Inquiry |
| SHW009185 | shRNA set against Danio rerio DGAT2 (NM_001030196) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCR369711 | Rat Dgat2 ORF Clone(NM_001012345.1) | Inquiry |
| CDFR002663 | Rat Dgat2 cDNA Clone(NM_001012345.1) | Inquiry |
| MiUTR1M-03822 | DGAT2 miRNA 3'UTR clone | Inquiry |
| MiUTR1R-01471 | DGAT2 miRNA 3'UTR clone | Inquiry |
| MiUTR3H-08873 | DGAT2 miRNA 3'UTR clone | Inquiry |
| SKO0428 | DGAT2 Validated sgRNA vector | Inquiry |
| SKO0429 | DGAT2 Validated sgRNA vector | Inquiry |
| CDCB159374 | Human DGAT2 ORF clone (BC015234) | Inquiry |
| CDCB170660 | Danio rerio DGAT2 ORF Clone (NM_001030196) | Inquiry |
| CDCB185030 | Rabbit DGAT2 ORF clone (XM_008263828.1) | Inquiry |
| CDCR055108 | Human DGAT2 ORF clone (NM_001253891.1) | Inquiry |
| CDCR055114 | Mouse Dgat2 ORF clone (NM_026384.3) | Inquiry |
| CDCS410000 | Human DGAT2 ORF Clone (BC015234) | Inquiry |
DGAT2 is the critical catalyzing enzyme for triglyceride biosynthesis. Diacylglycerol acyltransferases (DGATs) play a crucial role in the biosynthesis of triacylglycerol (TG), which is the main storage form of metabolic energy in eukaryotic organisms. Although DGAT2, one of the two different DGATs, plays an important role in TG biosynthesis, little is known about the regulation of DGAT2 activity. Two different diacylglycerol acyltransferases (DGAT) - DGAT1 and DGAT2 - are involved in catalysing the final step of TG biosynthesis by forming a covalent bond between acyl CoA and diacylglycerol (DG). They are both primarily localized in the endoplasmic reticulum (ER), but DGAT2 is also associated with mitochondria and lipid droplets. DGAT2 is highly expressed in liver and adipose tissue and uses nascent DG and de-synthesised fatty acids as substrates to mediate another pathway called glycerophosphate.
Role of DGAT2 in Lipid Metabolism
Dietary lipids are absorbed into the intestinal epithelium as fatty acids and converted to triglycerides by diacylglycerol acyltransferase (DGAT), which are then packaged in celiac particles or stored in cytoplasmic lipid droplets (LDs). Patients deficient in DGAT1 experience vomiting, diarrhoea and protein-losing enteropathy, illustrating the importance of this process to intestinal homeostasis. DGAT1 deficiency leads to reduced LD formation in the intestinal organ tissues of patients and resistance to unsaturated fatty acid lipotoxicity. However, LD formation is not completely lost in patient-derived organ tissues, suggesting an alternative mechanism for LD formation. An unexpected role of DGAT2 in lipid metabolism is suggested, as DGAT2 partially compensates for LD formation and lipotoxicity in DGAT1-deficient intestinal stem cells. Furthermore, (un)saturated fatty acid-induced lipotoxicity is mediated by ER stress. More importantly, overexpression of DGAT2 fully compensated for DGAT1 deficiency in organ tissues, suggesting that induction of DGAT2 expression in patient cells could serve as a future therapeutic target.
Role of DGAT1 And DGAT2 in The Gut
Effects of DGAT1 and DGAT2-mediated lipid metabolism on intestinal epithelial cell homeostasis. Epithelial stem cells express both functional DGAT1 and DGAT2, although DGAT2 was previously expressed only at very low levels in the human intestine. Furthermore, functional expression of DGAT2 is lost upon differentiation towards the enterocyte phenotype and that DGAT2 partially compensates for LD formation and resistance to lipotoxicity when DGAT1 function is inhibited in intestinal stem cells. DGAT1-dependent OA-induced LD formation is tolerated in the absence of DGAT1, which is also partially dependent on DGAT2. In addition, the protective effect of LD is linked to an attenuation of the lipid-induced ER stress response. Finally, overexpression of DGAT2 completely attenuated OA-mediated lipotoxicity in patient-derived DGAT1-deficient enterocytes.
Role of Cysteine And Its Oxidation in Human DGAT2 Enzyme Activity In Vitro
Thiol-modifying reagents (NEM and IA) as well as ROS-related chemicals (H2O2 and β-lapachone) severely inhibit human DGAT2 activity, whereas human DGAT1 and GPAT1 are virtually unaffected. In particular, ROS-related chemicals simultaneously induced intermolecular disulfide cross-linking in human DGAT2. After treatment with the disulfide bond reducer DTT, the oxidative inactivation and disulfide cross-linking were almost completely reversed, suggesting that ROS-induced intermolecular cross-linking plays an important role in the inactivation of human DGAT2 and that DGAT2 is a redox-sensitive regulator of TG biosynthesis.
References: